Kusumi I, Ito K, Honda M, Hayashishita T, Uemura K, Hashimoto N, Murasaki M, Atsumi Y, Kadowaki T, Koyama T: Screening for diabetes using Japanese monitoring guidance in schizophrenia patients treated with second-generation antipsychotics: A cross-sectional study using baseline data.", Psychiatry Clin Neurosci.65, 349-355, (2011)*
Kusumi I, Ito K, Uemura K, Honda M, Hayashishita T, Miyamoto K, Sawayama H, Kako Y, Tsuchida S, Hashimoto N, Koyama T: Screening for diabetes using monitoring guidance in schizophrenia patients treated with second-generation antipsychotics: A 1-year follow-up study.", Prog Neuropsychopharmacol Biol Psychiatry.35, 1922-1926, (2011)*
Kusumi I, Honda M, Uemura K, Sugawara Y, Kohsaka M, Tochigi A, Koyama T: Effect of olanzapine orally disintegrating tablet versus oral standard tablet on body weight in patients with schizophrenia: a randomized open-label trial.", Prog Neuropsychopharmacol Biol Psychiatry.36, 313-317, (2012)*
Sugawara H, Iwamoto K, Bundo M, Ueda J, Miyauchi T, Komori A, Kazuno A, Adati N, Kusumi I, Okazaki Y, Ishigooka J, Kojima T and Kato T: Hypermethylation of SLC6A4 in bipolar disorder detected by epigenome analysis of discordant twins.", Translational Psychiatry.1, e24; doi:10.1038/tp.2011.26, (2011)*
Shimazawa R, Kusumi I, Ikeda M: Delays in psychiatric drug development in Japan.", J Clin Pharm Ther. Oct 23. doi: 10.1111/j.1365-2710.2011.01311.x., (2011)*
Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N, Inoue T, Kusumi I, Koyama T, Tsuchiyama K, Terao T: DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.", PLoS One.6(8), e23881, (2011)*
Asakura S, Inoue T, Kitagawa N, Hasegawa M, Fujii Y, Kako Y, Nakato Y, Hashimoto N, Ito K, Tanaka T, Nakagawa S, Kusumi I, Koyama T: Social Anxiety / Taijin-kyofu Scale ・・ATS): development and psychometric evaluation of a new instrument.", Psychopathology.45, 67-72, 2012*
Boku S, Inoue T, Honma H et al: Olanzapine augmentation of milnacipran for stage 2 treatment-resistant major depression: an open study.", Hum Psychopharmacol, Epub ahead of print, (2011)*
2. Case report
Egashira T, Inoue T, Shirai Y, Iwata K, Honma J, Koyama T: "Adjunctive gabapentin for treatment-resistant insomnia of bipolar disorder: A case report", Clin Neuropharmacol.34, 129-30, (2011)*
